We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Role of Astrocytes Suggests Target for Stroke Therapy

By HospiMedica staff writers
Posted on 27 Sep 2004
A study has revealed that astrocytes have a primary role in regulating blood flow within the brain and therefore show promise as a target for new stroke therapies.

Astrocytes surround nerve cells and all blood vessels in the brain. More...
Researchers found that a rise of calcium within the astrocyte instructs the blood vessels to constrict, which alters blood flow. Brain blood supplies energy for brain activities. Vessel contraction and dilation are a normal part of brain functioning, but improperly regulated flow can result in brain disorder or damage.

A study has revealed that astrocytes have a primary role in regulating blood flow within the brain and therefore show promise as a target for new stroke therapies.

Astrocytes surround nerve cells and all blood vessels in the brain. Researchers found that a rise of calcium within the astrocyte instructs the blood vessels to constrict, which alters blood flow. Brain blood supplies energy for brain activities. Vessel contraction and dilation are a normal part of brain functioning, but improperly regulated flow can result in brain disorder or damage.

The new finding upsets prior theories that astrocytes might cause vessels to dilate. Next steps include determining how to block the calcium in astrocytes to reduce damage caused by inadequate blood flow to the brain. Calcium flow in the brain is not influenced by diet. The results of the two-year study were published in the September 8, 2004, issue of Nature.

"This discovery highlights the complex communication between astrocytes and blood vessels, and research can now be focused on understanding and controlling these communication pathways,” commented coauthor Brian MacVicar, a professor in the Brain Research Center and the department of psychiatry at the University of British Columbia (UBC, Vancouver, Canada).



Related Links:
University of British Columbia

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.